dipyridamole has been researched along with Invasiveness, Neoplasm in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mareel, M | 1 |
| Bracke, M | 1 |
| Bruyneel, E | 1 |
| Van Larebeke, N | 1 |
| De Mets, M | 2 |
| Mareel, MM | 1 |
2 reviews available for dipyridamole and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Invasion and metastasis control: implications for increased therapeutic index of antitumor drugs.
Topics: Antineoplastic Agents; Catechin; Dipyridamole; Glycoproteins; Humans; Microtubules; Neoplasm Invasiv | 1990 |
Anti-invasive activities of experimental chemotherapeutic agents.
Topics: Animals; Antineoplastic Agents; Catechin; Dipyridamole; Flavones; Flavonoids; Glucosidases; Glycosyl | 1989 |